Signal over noise: what will make AI stick in pharma R&D
Third-Party03/12/26
Johnson & Johnson invites AI and data science innovators, startups, academic leaders, investors and ecosystem partners to an afternoon discussion on what it will take for AI to move from experimentation and hype to durable impact in pharma R&D.
The program will explore where AI is already creating value, where evidence still needs to catch up with expectations, and how capabilities such as intelligent and agentic systems can support scientific reasoning, orchestrate workflows and help move teams faster from data to insight.
Join leaders from J&J and the Dutch innovation ecosystem at Startup Village in Amsterdam!